Aurcana Corp (AUNFF) 0.2241 $AUNFF Aurcana Corporation

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aurcana Corp (AUNFF) 0.2241 $AUNFF

Aurcana Corporation Update on Restructuring Transaction
Marketwired - Fri Dec 18, 8:01AM CST
Aurcana Corporation (TSX VENTURE: AUN)(OTCQX: AUNFF) (the "Company" reports that the anticipated outside date for completion of the previously announced restructuring transaction, under which all of the Company's secured debt obligations to Orion Mine Finance (Master) Fund I L.P., as lender under the Company's amended and restated senior secured credit facility dated April 29, 2014, as amended, will be extinguished, has been extended to January 8, 2016 to allow for additional time to complete the transaction and related implementation steps.
AUN.VN: 0.275 (+0.020)

Aurcana Reports Q3 2015 Financials And Provides Update on Restructuring Transaction
Marketwired - Tue Dec 01, 8:04AM CST
Aurcana Corporation ("Aurcana" or the "Company" (TSX VENTURE: AUN)(OTCQX: AUNFF) is pleased to report its unaudited financial results for the quarter ended September 30, 2015 ("Q3 2015" . The summary of the selected financial information in this press release should be read in conjunction with the unaudited financial statements and the related management's discussion and analysis for the three months ended September 30, 2015, together referred to as the "Financial Statements", which have been filed on SEDAR (www.sedar.com) and the Company's website (http://www.aurcana.com). All figures are in US dollars unless otherwise noted.
AUN.VN: 0.275 (+0.020)

Aurcana Corporation Announces Court Approval of Restructuring Transaction
Marketwired - Mon Nov 16, 8:03AM CST
Aurcana Corporation (TSX VENTURE: AUN) (the "Company" or "Aurcana" announces that on Friday, November 13, 2015, the Ontario Superior Court of Justice (the "Court" approved the restructuring transaction previously announced by the Company on October 16, 2015 (the "Restructuring Transaction" under which all of the Company's debt obligations to Orion Mine Finance (Master) Fund I L.P. (the "Lender" , as lender under the Company's amended and restated senior secured credit facility dated April 29, 2014 (the "Facility" , will be extinguished pursuant to proceedings under the Canada Business Corporations Act (the "CBCA Proceedings" commenced and announced by the Company on October 30, 2015.
AUN.VN: 0.275 (+0.020)

Aurcana Production Results for Q3 2015
Marketwired - Mon Oct 19, 8:02AM CDT
Aurcana Corporation ("Aurcana" or the "Company" (TSX VENTURE: AUN)(OTCQX: AUNFF) is pleased to report the Q3 2015 production results of 842,334 ounces silver equivalent compared to 997,530 in Q3 2014, a decrease of 16%. Silver production decreased by 15% to 348,764 in Q3 2015, compared to 412,063 in Q3 2014. Although milling and mining production increased during the third quarter, production occurred in lower grade areas of La Negra mine.
AUN.VN: 0.275 (+0.020)

Aurcana Corporation Announces Restructuring Transaction and Amendment of Senior Secured Credit Facility
Marketwired - Fri Oct 16, 8:16AM CDT
Aurcana Corporation (TSX VENTURE: AUN)(OTCQX: AUNFF) (the "Company" or "Aurcana" announces that it has entered into a Support Agreement (the "Support Agreement" with Orion Mine Finance (Master) Fund I L.P. (the "Lender" as lender under the amended and restated senior secured credit facility dated April 29, 2014 (the "Facility" to effect a restructuring transaction in connection with the debt obligations under the Facility (the "Restructuring Transaction" . The Company also announces certain amendments to the Facility.
AUN.VN: 0.275 (+0.020)

Aurcana Reports Q2 2015 Financials
Marketwired - Fri Aug 14, 8:01AM CDT
Aurcana Corporation ("Aurcana" or the "Company" (TSX VENTURE: AUN)(OTCQX: AUNFF) is pleased to report its unaudited financial results for the quarter ended June 30, 2015 ("Q2 2015" . The summary of the selected financial information in this press release should be read in conjunction with the unaudited financial statements and the related management's discussion and analysis for the three months ended June 30, 2015, together referred to as the "Financial Statements", which have been filed on SEDAR (www.sedar.com) and the Company's website (http://www.aurcana.com). All figures are in US dollars unless otherwise noted.
AUN.VN: 0.275 (+0.020)

Change of Auditor
Marketwired - Fri Jul 03, 6:48PM CDT
Aurcana Corporation ("Aurcana" or the "Company" (TSX VENTURE: AUN)(OTCQX: AUNFF) announces that it has changed its auditors from PricewaterhouseCoopers LLP (the "Former Auditors" to Deloitte, LLP (the "Successor Auditors" effective June 25, 2015.
AUN.VN: 0.275 (+0.020)

Aurcana Reports Q1 2015 Financials and Results of the 2015 Annual General Meeting
Marketwire Canada - Fri May 15, 7:30AM CDT
Aurcana Corporation ("Aurcana" or the "Company" (TSX VENTURE:AUN)(OTCQX:AUNFF) is pleased to report its unaudited financial results for the quarter ended March 31, 2015 ("Q1 2015" . The summary of the selected financial information in this press release should be read in conjunction with the unaudited financial statements and the related management's discussion and analysis for the three months ended March 31, 2015, together referred to as the "Financial Statements", which have been filed on SEDAR (www.sedar.com) and the Company's website (http://www.aurcana.com). All figures are in US dollars unless otherwise noted.
AUN.VN: 0.275 (+0.020)

Aurcana Reports 2014 Financial Results
Marketwired - Tue Apr 14, 11:16AM CDT
Aurcana Corporation ("Aurcana" or the "Company" (TSX VENTURE: AUN)(OTCQX: AUNFF) is pleased to report its audited financial results for December 31, 2014. The summary of the selected financial information should be read in conjunction with the audited financial statements and the related management's discussion and analysis dated April 13, 2015 together referred to as the "Financial Statements", which have been filed on SEDAR (www.sedar.com) and the Company's website (http://www.aurcana.com). All figures are in US dollars unless otherwise noted.
AUN.VN: 0.275 (+0.020)

Aurcana Announces Settlement of Class Action
Marketwired - Tue Feb 10, 4:51PM CST
Aurcana Corporation ("Aurcana" or the "Company" (TSX VENTURE: AUN)(OTCQX: AUNFF) announces that it has entered into an agreement (the "Settlement Agreement" to settle the class action litigation commenced by Nunzio Cardillo and John Witiluk in the Ontario Superior Court of Justice (the "Action" against the Company and two former executives of the Company (the "Settlement" .
AUN.VN: 0.275 (+0.020)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Schouw & Co.'s Share Buy-Back Strategy for 2025

Updated Category News Views 153

Overview of Schouw & Co.'s Share Buy-Back Program Schouw & Co. has launched an exciting share buy-back initiative, aiming to enhance shareholder value significantly. This program began on May 5, 2025, and is designed to repurchase shares totaling up to DKK 120 million. This investment runs until December 31, 2025, reflecting the company's commitment to its shareholders....

Continue Reading
Schneider National Plans to Reveal Q3 2024 Earnings Soon

Updated Category News Views 45

Schneider National to Report Third Quarter 2024 Earnings Schneider National, Inc. (NYSE: SNDR), a leader in transportation and logistics services, has announced that it will release its third quarter 2024 earnings report on a future date, ahead of the market opening. This announcement is significant as it highlights the company’s continued focus on financial...

Continue Reading
A Closer Look at BioAge Labs: Legal Challenges Ahead

Updated Category News Views 206

Understanding the Legal Landscape of BioAge Labs Investors in BioAge Labs, Inc. have faced new uncertainties as the clinical-stage biopharmaceutical company becomes entangled in legal challenges. As the firm moves forward in its mission to develop innovative therapies aimed at combating metabolic diseases, significant developments have emerged that every investor should...

Continue Reading
Celebrating the Fusion of Science and Cinema at Starmus 2025

Updated Category News Views 202

Fusion of Science and Cinema at Starmus Festival The Starmus Festival is a unique event that intertwines science and art, culminating in extraordinary dialogues and presentations. Recently, renowned director Christopher Nolan was awarded the prestigious Stephen Hawking Medal for Science Communication during this remarkable celebration. This accolade is not just an honor...

Continue Reading
Millicom Takes Steps to Enhance Transparency in Holdings

Updated Category News Views 82

Millicom Takes Steps to Enhance Transparency in Holdings Millicom International Cellular S.A., commonly recognized as Tigo, is making significant strides in open communication and compliance by submitting regulatory notifications regarding major shareholder holdings. This initiative reinforces their commitment to transparency and regulatory excellence in the ever-evolving...

Continue Reading